Latest Breaking News On - Warner chilcott - Page 7 : comparemela.com

Ulcerative Colitis Market Scenario 2020 – Current Trends, Size, Share and Future Opportunities by 2026 Global Ulcerative Colitis Market – Insights Ulcerative colitis (UC), also known as colitis ulcerosa, is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract. It is characterized by diarrhea, sudden and unexplained weight loss, loss of appetite, belly pain/cramps, bleeding from the rectum, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney stones, and liver disease. The inflammation results in development of tiny sores known as ulcers. Although the exact cause for UC is not known, probable factors include, genetic aspects, environmental changes, or weakened immune system. Healthy diet, proper hydration, skipping fatty foods, and limited consumption of high-fiber food can help to prevent UC. Although the incidence of the disease is high among people under 30 years of age, it may

United statesUnited kingdomOlsalazine dipentumAdalimumab humiraSulfasalazine azulfidineInfliximab remicadeVedolizumab entyvioMesalamine asacolAsia pacificBalsalazide colazalGolimumab simponiMinistry of healthJanssen pharmaceuticals incJanssen pharmaceutical companies of johnsonTakeda pharmaceutical companyGlobal ulcerative colitis market research